Compositions for controlled release of active agents

A composition of acrylate/VA and acrylate copolymers with 1,3-propanediol and glycerin controls porosity for efficient, irritation-free release of active ingredients on the skin, addressing robustness and ease of removal.

JP7817458B2Active Publication Date: 2026-02-18ELC MANAGEMENT LLC
View PDF 20 Cites 0 Cited by

Patent Information

Application Number
JP2024572723
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2022-06-10
Filing Date
2023-06-08
Publication Date
2026-02-18
Estimated Expiration
2043-06-08

AI Technical Summary

Technical Problem

Existing topical formulations for controlled release of active ingredients are not robust enough to maintain comfort on the skin for extended periods, are susceptible to contact migration, and lack efficient removal by rubbing with water.

Method used

A topical composition comprising a combination of acrylate/VA copolymer and acrylate copolymer in a specific weight ratio, along with 1,3-propanediol and glycerin as porosity control agents, forming a film with controlled porosity between 0.1 μm and 10 μm to achieve controlled release of active ingredients.

Benefits of technology

The composition provides a robust delivery system that minimizes skin irritation and contact migration while allowing easy removal with water, ensuring controlled and efficient release of active ingredients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007817458000001
    Figure 0007817458000001
  • Figure 0007817458000002
    Figure 0007817458000002
  • Figure 0007817458000003
    Figure 0007817458000003
Patent Text Reader

Abstract

A topical film-forming composition capable of efficiently delivering an active ingredient to the keratin surface in a sustained-release manner includes a combination of an acrylate copolymer and an acrylate / VA copolymer, and a combination of 1,3-propanediol and glycerin. The size of the pores formed in the dry film can be controlled or finely adjusted.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present invention is in the field of topical formulations for keratinous surfaces. More particularly, the present invention relates to film-forming compositions that can efficiently deliver active ingredients to the skin in a controlled release manner. [Background technology]

[0002] Co-owned applications US15 / 632903 (now US Patent No. 11,103,439), US15 / 906372 (now US Patent No. 10,813,874), US17 / 029147, US17 / 176527, US16 / 816995, US16 / 197858, US16 / 381806 (now US Patent No. 10,507,175), US16 / 267441 (now US Patent No. 10,980) In US 17 / 189768, US 16 / 827876 (now US Patent No. 11,129,788), all of which are incorporated herein by reference in their entireties, the applicant discloses specific combinations of acrylate / VA copolymers and acrylate copolymers in aqueous bases, and the various useful properties of these combinations depending on the application and presence of certain other ingredients. Although these compositions are water-based, they dry to a clear, flexible, and comfortable film upon application to the skin surface.

[0003] In US16 / 267441 (now US Patent No. 10,980,717), the present inventors disclosed a reduced ethanol fragrance composition comprising (based on the total weight of the composition) about 50-60% water, about 3-30% fragrance component, about 4.5-18.5% acrylate / VA copolymer, about 0.25-1.0% acrylate copolymer (wherein the weight ratio of the acrylate / VA copolymer to the acrylate copolymer is within the range of 10:1 to 30:1), and one or more plasticizers, which may be up to 4.5% glycol (butanediol, propanediol, pentylene glycol) or up to 5% alcohol, provided that the weight ratio of the acrylate / VA copolymer to the total plasticizers is within the range of 1:1 to 10:1. It has been noted that, in general, the more plasticizer in the aqueous phase, the larger the surface pore size tends to be in the film that is the dried product of the acrylate / VA copolymer-acrylate copolymer composition. Controlling this pore size is key to achieving controlled release of fragrance as a function of time. In comparison with the present invention, the inventors note that the diffusion of fragrance molecules from the fragrance components in the pores of the dried film to the atmosphere is not the same as the release of active ingredients from the pores of the dried film to the skin, which is facilitated by osmotic pressure.

[0004] In US 16 / 827876 (now US Patent No. 11,129,788), the inventors disclosed spray-on film-forming compositions containing (based on the total weight of the composition) about 70-85% water, about 4.7-14% acrylate / VA copolymer, about 0.05-2.5% acrylate copolymer, and about 1-5% plasticizer (which may be any one of glycerin, propanediol, butylene glycol, or a combination thereof). The weight ratio of acrylate / VA copolymer to acrylate copolymer was reported to be within the range of 1.8:1 to 280:1, preferably 10:1 to 100:1, more preferably 10:1 to 30:1, and most preferably 20:1. The plasticizer was reported to affect the porosity of the dried film. It was also reported that when these compositions were applied to a substrate and allowed to dry, the dried film had an average porosity of between 0.25 μm and 3.0 μm. Furthermore, it was noted that this pore size makes the disclosed compositions useful as delivery vehicles for active ingredients. Specifically, pore sizes of 0.9 μm to 2.5 μm are particularly useful for controlled or sustained release of active ingredients. Examples of active ingredients that may be incorporated into the aqueous phase or oil phase were disclosed.

[0005] None of the above references disclose a more robust delivery system for the controlled release of the following actives: [Prior art documents] [Patent documents]

[0006] [Patent Document 1] US15 / 632903 (now US Patent No. 11,103,439) [Patent Document 2] US15 / 906372 (now US Patent No. 10,813,874) [Patent Document 3] US17 / 029147 [Patent Document 4] US17 / 176527 [Patent Document 5] US16 / 816995 [Patent Document 6] US16 / 197858 [Patent Document 7] US16 / 381806 (now US Patent No. 10,507,175) [Patent Document 8] US16 / 267441 (now US Patent No. 10,980,717) [Patent Document 9] US17 / 189768 [Patent Document 10] US16 / 827876 (now US Patent No. 11,129,788) Summary of the Invention [Problem to be solved by the invention]

[0007] The primary objective of the present invention is to provide a more robust delivery system for the controlled release of actives that is comfortable on the skin for extended periods of time, is less susceptible to contact migration, yet is easily removed by rubbing in water. [Means for solving the problem]

[0008] Topical compositions for controlled release of active ingredients contain 20% to 60% by weight of a combination of an acrylate copolymer and an acrylate / VA copolymer, with the weight ratio of the acrylate / VA copolymer to the acrylate copolymer ranging from 10:1 to 30:1, preferably from 15:1 to 25:1, and more preferably about 20:1. The compositions also contain 5.5% to 10%, preferably 6% to 7%, of a combination of 1,3-propanediol and glycerin, with the weight ratio of the 1,3-propanediol to the glycerin ranging from about 1:1 to about 4:1, preferably from about 2:1 to about 3:1. When these compositions are applied to a substrate, such as a keratin surface, and allowed to dry, the dried film has an average porosity of between about 0.1 μm and about 10 μm. DETAILED DESCRIPTION OF THE INVENTION

[0009] Except in operating and comparative examples, or unless otherwise expressly indicated, all numbers in this description suggesting amounts or ratios of ingredients, or conditions of reactions, physical properties of ingredients, and / or use, should be understood to be modified by the term "about." All amounts are expressed as weight percentages of the final composition unless otherwise specified.

[0010] Throughout this specification, "film former" or the like means a polymer that leaves a film on a substrate to which it is applied, for example, after the solvent with which the film former is carried has evaporated on the substrate, absorbed into the substrate, and / or dissipated on the substrate.

[0011] "Comprise" means that the set of elements may not be limited to those explicitly recited.

[0012] Acrylates / VA Copolymer The first major component of the present invention is Acrylates / VA Copolymer (INCI name), C 15 H 26 O4, also known as ethenyl acetate or 2-ethylhexylprop-2-enoate (IUPAC name), CAS number 25067-02-1. For more information, see CID=168269 in the PubChem compound database.

[0013] [ka]

[0014] In cosmetics, this tacky material often functions as a binder, film former, adhesive, and / or hair fixative. When incorporated into aqueous cosmetic systems, acrylate / VA copolymers can impart a film on the skin or hair. Pure acrylate / VA copolymer films are characterized by a temperature dependency in that the film breaks down and can be removed from the surface when rinsed with water above about 38°C, but retains its integrity at temperatures below normal skin temperature (i.e., 36.5-37.5°C).

[0015] Acrylate / VA copolymers are commercially available, for example, from Daido Chemical Co., Ltd. as Vinysol 2140L. Vinysol 2140L is a 46.6% aqueous mixture of acrylate / VA copolymers. Vinysol 2140L has a pH of 4.5, a viscosity of 2,000 mPa-s, and a calculated glass transition temperature (T) of -9°C. ag ), while the coating exhibits a breaking elongation of 1,200% and a breaking strength of 1.2 MPa (when stretched to a thickness of 0.1 mm). By itself, the acrylate / VA copolymer is slightly too stiff for consumer acceptance.

[0016] Acrylates Copolymer To address this issue of extreme hardness, the acrylate / VA copolymer was replaced with an acrylate copolymer, C 14 H 22 O6, which is also known as ethyl prop-2-enoate, methyl 2-methylprop-2-enoate, or 2-methylprop-2-enoic acid (IUPAC name, CAS number 25133-97-5). This acrylate copolymer has a lower T than the acrylate / VA copolymer. g For more information, see CID=168299 in the PubChem compound database. In various types of cosmetic formulations, acrylate copolymers have a wide variety of uses, including film formers, hair fixatives, binders, as well as suspending agents, viscosity enhancers, antistatic agents, and adhesives.

[0017] Acrylate copolymers are commercially available, for example, from Daito Chemical Industry Co., Ltd. as Daitosol 5000AD. Daitosol 5000AD is a 50% aqueous mixture of acrylate copolymers. Daitosol 5000AD has a pH of 5.5-7.5, a viscosity of 50-100 mPa-s, and a glass transition temperature (Tg) of approximately -14°C. g ) has been reported.

[0018] The topical aqueous compositions of the present invention comprise a film-forming agent comprising an acrylate / VA copolymer and an acrylate copolymer in a weight ratio of 10:1 to 30:1, with the combined weight of the acrylate / VA copolymer and the acrylate copolymer being 20% ​​to 60% of the total composition. Preferably, the weight ratio of the acrylate / VA copolymer to the acrylate copolymer is about 15:1 to 25:1, more preferably about 20:1, e.g., 19:1 to 21:1. For example, one useful embodiment of the composition comprises 40% acrylate / VA copolymer and 2% acrylate copolymer.

[0019] Porosity control agent As mentioned above, the composition according to the present invention is water-based, but when applied to the skin, it dries to form a porous film.As the film dries, the molecules of the active ingredient(s) accumulate in the pores of the dry film, preventing significant amounts of the active ingredient(s) from agglomerating.This ensures that the particle size of the active ingredient(s) remains small enough to penetrate the skin.Then, under the effect of osmotic pressure, these active molecules are released from the pores of the film into the skin.

[0020] However, it is generally necessary to further adjust the porosity so that the release of the incorporated molecules is neither too slow nor too fast. If the release is too slow, the active ingredient may not produce the desired effect on the skin. If the release is too fast, the active ingredient is likely to irritate the skin. The inventors have discovered a method for controlling the release of active materials from the above-described films by adjusting the porosity of the film without compromising many of the film's useful properties, particularly breathability. By breathability, the inventors mean the air permeability of the dried film. Typically, it has been observed that the compositions of the present invention, when dried, allow air to pass through even at ambient pressures as low as 1 psi. Maintaining the breathability of the dried film is important for the comfort of the user.

[0021] Porosity (or pore size) is controlled by including a porosity control agent in the composition. The porosity control agent comprises 1,3-propanediol and glycerin in a weight ratio of about 1:1 to 4:1, with the combined weight of the 1,3-propanediol and glycerin comprising about 5.5% to 10% of the total composition weight. Preferably, the weight ratio of the 1,3-propanediol to glycerin is about 1:1 to 3:1, more preferably about 2:1 to 2.5:1. Preferably, the combined weight of the 1,3-propanediol and glycerin ranges from about 5.5% to about 7%, more preferably about 6%, of the total weight of the composition. For example, a porosity control agent consisting of a combination of 4% 1,3-propanediol and 2% glycerin, totaling 6%, satisfies this requirement.

[0022] As described above, the inventors have observed that the pore size of a dried film can be controlled or fine-tuned by the combination of 1,3-propanediol and glycerin as defined above. Generally, a larger (smaller) amount of porosity control agent results in a film with larger (smaller) pores on average. Using the concentrations disclosed above, it is possible to produce films with average pore sizes ranging from about 0.1 μm to 10 μm, and the average pore size range can be fine-tuned. For example, it is possible to produce polymeric films in which 75% to 90% of the pore sizes are within about 1 μm, with the remaining 10% to 25% being above and below this range. The inventors have produced polymeric films according to the present invention, for example, in which about 80% of the pores are in the 1.75 to 2.75 μm range, about 10% are in the 1.00 to 1.75 μm range, and about 10% are in the 2.75 to 3.75 μm range. Larger pores may release the active ingredient faster than ideal, but the amount of active released will be relatively small and less likely to cause irritation. Because all or most of the active ingredient is trapped in similarly sized pores (within about 1 μm), the release of most of the active ingredient can be controlled. If the pore size distribution is too wide, it is unlikely that controlled release suitable for the topical personal care market will be achieved. In the compositions of the present invention, 75% to 90% of the pore sizes in the dry polymeric film are preferably within about 2 μm, more preferably within about 1.5 μm, and most preferably within about 1.0 μm.

[0023] active ingredient The active ingredient may be incorporated into the aqueous phase or the oil phase, if present. Non-limiting examples of hydrophilic (water-soluble) actives include algae extract, alpinia speciosa leaf extract, Alteromonas ferment extract, ascorbyl acid glucoside (AA2G), citrullus lanatus (watermelon) fruit extract, crataegus monogyna (hawthorn) flower extract, hyaluronic acid, hydrolyzed yeast protein, Lactobacillus ferment filtrate, matricaria (chamomile) extract, lens esculenta (lentil) fruit extract, paeonia suffruticosa (peony) root extract, panthenol, pyrus malus (apple) fruit extract, and saccharum officinarum extract. Non-limiting examples of hydrophobic (oil-soluble) actives include Anthemis nobilis oil, bht (dibutylhydroxytoluene), caffeine, coconut oil, salicylic acid, vitamin A, tetrahexyldecyl ascorbate, and tocopheryl acetate. The combined concentration of all active ingredients typically varies from 0.0001% to about 10% by weight of the composition.

[0024] water The compositions of the present invention are water-soluble and typically contain at least about 25% water by weight of the total composition. Preferably, the total amount of water is at least 50%. This amount of water includes water from all sources, such as Vinysol 2140L and Daitosol 5000AD.

[0025] Optional Ingredients The compositions of the present invention may optionally contain a preservative, typically at a level of up to about 2% by weight of the composition. Viscosity modifiers and / or pH adjusters may also be used as needed, typically at levels less than 1% by weight of the composition, to create a consumer-acceptable product. At these levels, preservatives, viscosity modifiers, and pH adjusters are not expected to adversely affect the controlled release of the active from the dry polymeric film.

[0026] Some preferred embodiments of the present invention are single-phase aqueous compositions having little or no oil or silicone. However, in other preferred embodiments, the compositions are lightly emulsified oil-in-water emulsions. Emulsion embodiments are useful when the compositions are used to deliver at least one oil-soluble active (e.g., vitamin E acetate) to keratinous surfaces. Emulsion embodiments may contain one or more surfactants or emulsifiers having an HLB between 8 and 12, which may be present in amounts of up to 2% of the total composition, typically between 0.01% and 2% of the total composition.

[0027] Agents that significantly interfere with the structure of the dried film can adversely affect the controlled release of the active from the dried polymeric film. Therefore, the compositions of the present invention preferably contain no more than 0.5% total structuring agent, e.g., 0.0001% to 0.5% of a structuring agent, such as Carbopol®, wax, clay (e.g., bentonite), or stearic acid. More preferably, the compositions of the present invention contain no more than 0.001% total structuring agent. Most preferably, the compositions of the present invention contain no structuring agent at all. A useful exception to this rule is sodium stearate. Unlike many structuring agents, sodium stearate is partially hydrophilic, making it suitable for aqueous systems. While sodium stearate is partially hydrophobic, its use does not appear to be a problem for the purposes of the present invention. This makes sodium stearate particularly useful in embodiments of the present invention where a structuring agent may be required. Sodium stearate may be used as a structuring agent at 0.0001% to 4% by weight of the total composition. Exceeding that amount can begin to disrupt the acrylic bond strength, which can adversely affect the controlled release of the active from the dried polymeric film.

[0028] The inventors note that polyurethanes not only tend to make the compositions of the present invention very hard, but also adversely affect the controlled release of the active from the dried polymeric film. Therefore, the film-forming compositions of the present invention contain no more than 0.5% polyurethane, e.g., 0.0001% to 0.5%. More preferably, the compositions of the present invention are free of polyurethane.

[0029] Delivery of active ingredients When the composition according to the invention is applied to a substrate and allowed to dry, the dried film has pores in which the molecules of the active ingredient accumulate, after which osmotic pressure drives the active molecules out of the pores of the film and into the skin.

[0030] In practice, the porosity of the dry film is selected based on the molecular weight of the active material and the desired release rate. Generally, the larger the molecular weight of the active ingredient, the larger the pore size required to allow the active ingredient molecules to accumulate in the pores of the film. The release rate is selected based on the active's tendency to irritate the skin versus the intended benefit. A slow release rate (small porosity) may be required to avoid unacceptable levels of irritation, but a release rate that is too slow may not provide any significant benefit. By routine trial and error, a film with a specific pore size distribution and release rate can be obtained for each specific active.

[0031] For example, a useful composition according to the present invention in which the active ingredient is glycolic acid (hydrophilic, molecular weight 76.05 g / mol) had an average pore size of about 1.5 μm. Another composition according to the present invention in which the active ingredient is salicylic acid (hydrophobic, molecular weight 138 g / mol) had a useful average pore size ranging from about 1.6 μm to about 3.0 μm. For molecular weights in the range of about 30 to about 90 g / mol, useful average pore sizes can more commonly range from about 0.1 μm to about 1.5 μm. For molecular weights in the range of 90 to 300 g / mol, useful average pore sizes can range from about 1.5 μm to about 3.0 μm. Furthermore, topical compositions according to the present invention exhibit controlled release of the active ingredient, significantly reducing or eliminating skin inflammation or irritation, when the pore size of the dry film is adjusted based on the molecular weight of the active molecule. The following example demonstrates controlled release of salicylic acid from a composition according to the present invention containing 1% salicylic acid. [Example]

[0032] [Table 1]

[0033] [Table 2]

[0034] [Table 3]

[0035] Control 2 and blank skin served as baselines for fluorescence measurements. As Table 3 shows, there was little transfer of salicylic acid from Control 2. Control 2, lacking the porosity modifier (i.e., the combination of 1,3-propanediol and glycerin), is an ineffective delivery system for the active ingredient.

[0036] On the other hand, Control 1 showed significant migration of salicylic acid. However, Control 1 has a significantly lower pH and a higher cationic charge than Examples 1, 2, and 3 and Control 2. Generally, a low pH and a high cationic charge improve the penetration of actives into the skin. However, a low pH is not suitable for topical skin products. Thus, Examples 1, 2, and 3 according to the present invention provide an alternative means of significant delivery of actives. Furthermore, when compared over 24 hours, very little salicylic acid was released from Control 1. This is because Control 1 experienced free release, in contrast to Examples 1, 2, and 3, which exhibited controlled release, meaning gradual release over time. Based on the standard deviation of migration reported in Table 3, Example 2 provided better results (more controlled release) than Examples 1 and 3.

[0037] While particular embodiments of the present invention have been described, it will be apparent to those skilled in the art that other modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all modifications that are within the scope of this invention.

Claims

1. 1. A topical aqueous composition for controlled release of an active ingredient, comprising: a film former comprising an acrylate / VA copolymer and an acrylate copolymer in a weight ratio of 10:1 to 30:1, wherein the combined weight of the acrylate / VA copolymer and the acrylate copolymer is 20% to 60% of the total composition weight; a porosity control agent comprising 1,3-propanediol and glycerin in a weight ratio of 1:1 to 4:1, wherein the combined weight of the 1,3-propanediol and glycerin is 5.5% to 10% based on the total weight of the composition; one or more cosmetically acceptable active ingredients in a total concentration of 0.0001% to 10% by weight of the composition; A topical aqueous composition comprising:

2. 10. The topical aqueous composition of claim 1, wherein the active ingredient is salicylic acid.

3. 10. The topical aqueous composition of claim 1, wherein the active ingredient is hyaluronic acid.

4. 10. The topical aqueous composition of claim 1, wherein the active ingredient is glycolic acid.

5. 10. The topical aqueous composition of claim 1, wherein the weight ratio of acrylate / VA copolymer to acrylate copolymer ranges from 15:1 to 25:

1.

6. 10. The topical aqueous composition of claim 1, wherein the weight ratio of 1,3-propanediol to glycerin ranges from 1:1 to 3:

1.

7. 10. The topical aqueous composition of claim 1, comprising 1,3-propanediol and glycerin in a combined amount of 5.5% to 7% by weight of the total composition.

8. 10. The topical aqueous composition of claim 1, wherein the active ingredient accumulates in pores that form in a coating when the composition is applied to a substrate and allowed to dry.

9. 9. The topical aqueous composition of claim 8, wherein the average pore size ranges from about 0.1 μm to about 1.5 μm.

10. 9. The topical aqueous composition of claim 8, wherein the average pore size ranges from about 1.5 μm to about 3.0 μm.

Citation Information

Patent Citations

  • Sprayable film-forming compositions for improving the performance of topical formulations - Patent Application 20070122997

    JP2022525246A

  • Long-lasting skin care composition

    JP2022525462A

  • Sheer-thinning cosmetic composition

    JP2023519767A

  • US10,507,175

  • US10,813,874